- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Allergy&Clinical Immunology
- Anesthesiology
- Business of Medicine
- Cardiology
- Critical Care
- Dental&Oral Health
- Dermatology
- Diabetes&Endocrinology
- Emergency Medicine
- Family Medicine/Primary Care
- Gastroenterology
- General Surgery
- Hematology-Oncology
- HIV/AIDS
- Hospital Medicine
- Infectious Diseases
- Internal Medicine
- Med Students
- Medscape Today
- Nephrology
- Neurology&Neurosurgery
- News
- News Alert
- None
- Nursing
- Ob/Gyn&Women's Health
- Ophthalmology
- Orthopaedics
- Pathology&Lab Medicine
- Pediatrics
- Pharmacist
- Plastic Surgery&Aesthetic Medicine
- Psychiatry
- Public Health&Prevention
- Pulmonary Medicine
- Radiology
- Rheumatology
- Transplantation
- Urology
November 8, 2022
Published by Med Search on November 8, 2022
Categories
Docket Number: FDA-2020-D-2107 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Drug approvals in oncology often build […]
November 8, 2022
Published by Med Search on November 8, 2022
Categories
[11-8-2022] Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to […]
November 8, 2022
Published by Med Search on November 8, 2022
Categories
Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Ruben De Quesada Recipient Title General Manager Omega & Delta Co., Inc. Carr. 887 Km 0 […]
November 8, 2022
Published by Med Search on November 8, 2022
Categories
Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Shan Umer Recipient Title President The Anthos Group, Inc. 705 N Douglas StreetEl Segundo, CA 90245United […]
November 8, 2022
Published by Med Search on November 8, 2022
Categories
Delivery Method: VIA EMAIL CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Mr. Giovanni Caforio Recipient Title Chief Executive Officer Abraxis Bioscience LLC 620 N 51st Ave.Phoenix, […]
November 8, 2022
Published by Med Search on November 8, 2022
Categories
Submit Comments by 01/08/2023 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]
November 7, 2022
Published by Med Search on November 7, 2022
Categories
Joan: Welcome to the CDER Small Business and Industry Assistance (SBIA) Chronicles Podcast Series. Today’s topic: The FDA Compounding Incidents Program: Adverse Events Associated with Compounded […]
November 7, 2022
Published by Med Search on November 7, 2022
Categories
On average, FDA determines that the vast majority of all expanded access requests may proceed. Sometimes called “compassionate use”, expanded access is a potential pathway for […]
November 7, 2022
Published by Med Search on November 7, 2022
Categories
Summary Company Announcement Date: November 05, 2022 FDA Publish Date: November 07, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of methanol Company […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140
Next page